Updated: January 6, 2026
How to Help Your Patients Find Raldesy in Stock: A Provider's Guide
Author
Peter Daggett

Summarize with AI
- Why Patients Are Struggling to Fill Raldesy Prescriptions
- Strategy 1: Submit a Strong Prior Authorization Request
- Strategy 2: Direct Patients to the Raldesy Patient Support Program
- Strategy 3: Connect Patients With Pharmacy Finder Tools
- Strategy 4: Work With Pharmacy to Enable Special Orders
- Strategy 5: Consider Specialty Pharmacy Referral
- When to Consider a Clinical Alternative
A practical guide for providers on helping patients access Raldesy (trazodone oral solution) in 2026 — from prior auth strategies to patient support program referrals.
When you prescribe Raldesy (trazodone hydrochloride oral solution) for a patient with major depressive disorder who cannot swallow tablets, the clinical decision is straightforward. The logistical reality is more complex. As a brand-only specialty liquid that's relatively new to the market (FDA approved in 2024), Raldesy is not yet stocked at every pharmacy — and patients may need significant support to secure their prescription. This guide gives you concrete, actionable steps to improve your patients' access to Raldesy in 2026.
Why Patients Are Struggling to Fill Raldesy Prescriptions
Before addressing solutions, it's helpful to understand the specific barriers your patients face:
Limited stocking: Many retail pharmacies have not yet added Raldesy to their automatic order lists. It's a newer brand-only specialty liquid with higher per-unit cost than generic trazodone tablets.
Insurance barriers: Medicare Part D does not generally cover Raldesy. Commercial plans often require prior authorization before coverage, and some plans exclude brand-only antidepressants entirely when generics are available.
High out-of-pocket cost: At $390–$456 retail per 150 mL bottle (30-day supply) without insurance assistance, many patients abandon the prescription.
Patient limitations: The patients who most need Raldesy — those with swallowing difficulties, cognitive impairment, or caregiver-dependent administration — are often least able to navigate multiple pharmacy phone calls or online search tools independently.
Strategy 1: Submit a Strong Prior Authorization Request
A well-documented prior authorization request is the cornerstone of insurance access for Raldesy. For commercially insured patients, PA is frequently required. A strong PA submission includes:
ICD-10 diagnosis code for MDD (F32.0–F32.9 for single episode; F33.0–F33.9 for recurrent)
Specific documented reason for liquid formulation (e.g., dysphagia ICD-10 R13.1x, post-stroke, dementia, post-surgical, or caregiver administration)
Statement that non-FDA-approved compounded liquid trazodone poses quality/consistency risks compared to Raldesy
Clinical notes documenting the patient's inability to safely take tablets
If the first PA request is denied, submit an appeal with additional supporting documentation. Appeals that include physician attestation and clinical notes succeed at significantly higher rates than initial requests.
Strategy 2: Direct Patients to the Raldesy Patient Support Program
Validus Pharmaceuticals offers the Raldesy Liquid Innovation With Care Patient Support Program, which provides meaningful cost relief:
Copay card: Commercially insured patients may pay as little as $10 for a 30-day supply (maximum $200 savings) or $20 for a 31–90 day supply (maximum $300 savings)
Patient assistance program: Uninsured patients who meet eligibility requirements may receive Raldesy at no cost; patients whose insurers are not covering Raldesy may also qualify for reduced-cost access
Contact: ConnectiveRx at 877-384-1417 or patient.raldesy.com
Note: The copay card is not available to patients receiving reimbursement under federal or state programs (Medicare, Medicaid, TRICARE, VA). For Medicare patients, explore the patient assistance program or consider a clinically appropriate alternative.
Strategy 3: Connect Patients With Pharmacy Finder Tools
For patients who are mobile and able to navigate phone or web tools, medfinder for providers offers a service that contacts pharmacies on patients' behalf to find which ones have a medication in stock. This is particularly valuable for elderly patients or those with cognitive limitations who may be overwhelmed by the process of calling multiple pharmacies.
For patients who cannot navigate this themselves, care coordinators, social workers, or caregiver family members can initiate the medfinder search on their behalf. Building this step into your prescribing workflow for Raldesy patients can prevent prescription abandonment.
Strategy 4: Work With Pharmacy to Enable Special Orders
Most major pharmacy chains and independent pharmacies can order Raldesy within 1–2 business days if they don't have it on the shelf. Coach patients (or their caregivers) to:
Bring the prescription to the pharmacy counter (don't call — in-person is more effective)
Ask specifically: "Can you order Raldesy trazodone oral solution 10 mg/mL? I can return in 1–2 days."
Get the pharmacist's name and a callback number to confirm when the order arrives
Strategy 5: Consider Specialty Pharmacy Referral
For patients who are consistently unable to locate Raldesy at retail pharmacies, consider routing the prescription to a specialty pharmacy. Walgreens Specialty Pharmacy, CVS Specialty, and certain regional specialty pharmacies have established distribution relationships for newer branded medications and are more likely to carry or rapidly procure Raldesy.
When to Consider a Clinical Alternative
If after exhausting access pathways a patient still cannot secure Raldesy, a clinical alternative should be discussed. For a full review of prescribing alternatives and their clinical context, see our provider overview on Raldesy shortage: what providers need to know.
Key options include compounded liquid trazodone (bridge), sertraline oral concentrate, escitalopram oral solution, and mirtazapine ODT. The clinical choice depends on the patient's primary symptom profile, comorbidities, and reason for needing a liquid formulation.
Frequently Asked Questions
Submit a prior authorization request that includes the MDD diagnosis (ICD-10 F32/F33), documented medical necessity for liquid formulation (e.g., dysphagia, caregiver administration), evidence tablets are not feasible, and a note that compounded liquid trazodone lacks FDA approval. PA decisions for commercial plans typically take 24–72 hours.
Yes. Validus Pharmaceuticals offers the Raldesy Liquid Innovation With Care Patient Support Program. Commercially insured patients may pay as little as $10/month via copay card. Uninsured patients who meet eligibility requirements may receive Raldesy at no cost. Contact ConnectiveRx at 877-384-1417 or visit patient.raldesy.com.
Yes. Raldesy (trazodone) is not a controlled substance and has no DEA restrictions on electronic prescribing. You can e-prescribe it through your EHR system like any other non-controlled medication.
Specialty pharmacies (Walgreens Specialty, CVS Specialty) are generally more likely to carry Raldesy than standard retail locations. Major chain pharmacies can special-order Raldesy within 1–2 business days if not stocked. Use medfinder to have local pharmacies checked on your patients' behalf.
FDA-approved liquid antidepressant options include sertraline oral concentrate (20 mg/mL, generic available) and escitalopram oral solution (1 mg/mL, generic available). Mirtazapine orally disintegrating tablets (ODT) are also useful for patients with swallowing difficulties. Compounded liquid trazodone from a 503A pharmacy is a bridge option but is not FDA-approved.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Raldesy also looked for:
More about Raldesy
35,524 have already found their meds with Medfinder.
Start your search today.





